CPAN Applauds Olatunji-Koolchap on Conferment of Doctorate in Pharmaceutical Practice

The Clinical Pharmacists Association of Nigeria (CPAN) has commended Dr Algreen A. Olatunji-Koolchap following the conferment of a prestigious Doctor of Science (D.Sc) in Pharmaceutical Practice by Prowess University, State of Delaware, USA.

In an official statement signed by the National Publicity Secretary of CPAN, Dr Timipre Okeroghene Aghogho, the association described the honour as a well-deserved recognition of Dr Olatunji-Koolchap’s exceptional commitment to the advancement of clinical pharmacy and pharmaceutical practice in Nigeria and beyond.

The statement, issued on behalf of the National Executive Council, Governing Council, and the entire CPAN membership, extolled Dr Olatunji-Koolchap’s “tireless dedication, unwavering commitment, and unrelenting passion for excellence” in professional practice, academic advancement, and policy advocacy.

“Dr Olatunji-Koolchap’s attainment of a doctorate in pharmaceutical practice is not just a personal milestone but a collective victory for the clinical pharmacy community in Nigeria. His relentless pursuit of knowledge, innovation, and mentorship has inspired many within and outside the profession,” the statement read.

CPAN emphasised that the honour reflects the growing relevance of pharmacy-led interventions in healthcare delivery, stressing that Dr. Olatunji-Koolchap’s professional journey has embodied the core ideals of clinical pharmacy — excellence, service, and evidence-based practice.

While congratulating him on the achievement, the association also acknowledged his longstanding contributions to policy dialogue, pharmaceutical care development, and pharmacist-led initiatives across healthcare systems in Nigeria.

“This academic recognition from an international institution further validates the global impact of his work and the standards he continues to uphold in the profession,” CPAN stated.

The association expressed confidence that Dr Olatunji-Koolchap would leverage this new academic height to expand his influence and contribute more robustly to the growth of pharmaceutical sciences and clinical pharmacy practice.